Mph Mittelstaendische Pharma Holding AG operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mph Mittelstaendische Pharma Holding AG with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £144.03 million [US$186.81 million]
of which 100%
was Antibodies & Related Products),
Laboratorios Farmaceuticos Rovi S.A.
(246.01 million Euro [US$274.56 million]
of which 82%
was Marketing), and
Eczacibasi Ilac Sanayi ve T.A.S.
based in Turkey
(1.17 billion Turkish Liras [US$328.06 million]
of which 72%
was Personal Care).
Mph Mittelstaendische Pharma Holding AG reported sales of 262.89 million Euro (US$293.40 million)
December of 2015.
increase of 19.9%
versus 2014, when the company's sales were 219.25 million Euro.